Watchlist Price Alert

Bicara Therapeutics Inc. ... (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

9.43

-0.24 (-2.48%)

At close: Jun 18, 2025, 1:59 PM

Bicara Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Net Income	-36.85M	-20.96M	-17.48M	-14.78M	-14.78M	-12.44M	-22.84M	-8.35M	-8.35M
Depreciation & Amortization	19K	15K	15K	13K	13K	14K	2K	1.5K	1.5K
Stock-Based Compensation	3.45M	3.18M	2.03M	1.09M	1.09M	765K	519K	307.5K	307.5K
Other Working Capital	n/a	-11.99M	-1.86M	-155.5K	-155.5K	2.94M	-1.56M	-440K	-440K
Other Non-Cash Items	n/a	-276K	68K	81K	81K	681K	13.35M	-5.05M	-5.05M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	-11.99M	-1.86M	-155.5K	-155.5K	2.94M	-1.56M	-440K	-440K
Operating Cash Flow	-28.11M	-30.03M	-17.22M	-13.75M	-13.75M	-8.04M	-10.53M	-13.53M	-13.53M
Capital Expenditures	n/a	-40K	-8K	-11.5K	-11.5K	-436K	-150K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	31K	31K	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	-40K	-8K	19.5K	19.5K	-436K	-150K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	460K	77K	334.13M	435.5K	435.5K	n/a	84K	18.95M	18.95M
Financial Cash Flow	460K	-975K	334.13M	435.5K	435.5K	194.7M	39.9M	18.95M	18.95M
Net Cash Flow	-27.65M	-31.05M	316.9M	n/a	n/a	186.23M	29.22M	14.99M	n/a
Free Cash Flow	-28.11M	-30.07M	-17.23M	-13.76M	-13.76M	-8.47M	-10.68M	-13.53M	-13.53M